RT @A_Shenol
1/3 Check this out! Our groups @Metabolcenter,have discovered a new class of dual-acting FFAR1/FFAR4 agonists.
Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00160#.Y3DcaFInDos.twitter